Fatigue is one of the most common and underappreciated symptoms of amyotrophic lateral sclerosis. In the largest study to date, involving over a thousand people with ALS, nearly 98 percent reported some degree of fatigue, with roughly a third experiencing it at a severe level. The tiredness that accompanies ALS runs deeper than what most people expect from a disease primarily known for progressive muscle weakness, and understanding where it comes from changes how patients and clinicians approach it.
How Common Is Fatigue in ALS
Estimates of fatigue prevalence in ALS vary depending on how researchers measure it and where they set the threshold for “clinically significant.” A systematic review and meta-analysis pooling data across multiple studies found that people with more advanced disease, as measured by lower scores on a standard functional scale, reported fatigue at a rate of about 62 percent, while those with less severe disease reported it around 43 percent of the time.1PubMed Central. Prevalence and correlates of fatigue in amyotrophic lateral sclerosis: A systematic review and meta-analysis A Brazilian study using a common screening tool, the Fatigue Severity Scale, classified about 45 percent of its participants as fatigued.2PubMed Central. Fatigue in amyotrophic lateral sclerosis and correlated factors But the picture shifts dramatically when researchers use instruments specifically designed for neurological fatigue rather than generic cut-offs. A 2025 study of over 1,000 people with ALS found that nearly all of them reported fatigue on a disease-specific measure, with about 36 percent classified as moderate and another 36 percent as severe.3PubMed. Fatigue in amyotrophic lateral sclerosis/motor neuron disease: prevalence, influences and trajectories
These numbers tell us something useful: fatigue in ALS is not a side complaint that affects a small slice of patients. It is close to universal, though how much it interferes with daily life varies widely from person to person. And for most people, it does not get dramatically worse over time. That same large study found that about 60 percent of participants had stable fatigue levels over an average follow-up of nearly a year, while about 24 percent worsened and roughly 16 percent actually improved.3PubMed. Fatigue in amyotrophic lateral sclerosis/motor neuron disease: prevalence, influences and trajectories That stability matters because it means fatigue is not just a mirror of disease progression. Something else is going on.
Fatigue Is Not the Same as Weakness
This is the single most important distinction for anyone living with ALS or caring for someone who does. Weakness means a muscle cannot generate as much force as it once could, because motor neurons have died and fewer signals reach the muscle fibers. Fatigue means that muscles tire out faster during repeated use, even if they still have some baseline strength left. The two symptoms overlap in daily life, but they are driven by different things and respond to different strategies.
Researchers have tested this by measuring how quickly muscle force drops during sustained or repeated contractions in ALS patients compared to healthy controls. In one study, fatigue was significantly greater in people with ALS across all muscles tested, with an average force decline of about 23 percent compared to 15 percent in controls. Critically, this included muscles that were not obviously weak on clinical examination, and the correlation between weakness and fatigue was poor.4PubMed. Quantitative assessment of motor fatigue in amyotrophic lateral sclerosis In other words, a muscle that still passes a standard strength test can fail more quickly under real-world use than a healthy person’s muscle would. You might be able to grip a jar but find that after a few minutes of cooking, your hand is spent in a way that feels disproportionate to the effort involved.
This disconnect between how strong a muscle seems on paper and how fast it runs out of steam helps explain why patients sometimes feel dismissed when they report overwhelming tiredness. Their strength tests may look reasonable for their disease stage, but their lived experience of exhaustion is real and measurable.
Where the Fatigue Comes From
ALS fatigue is not one thing. It arises from multiple overlapping problems, some inside the brain, some at the nerve-muscle connection, and some in the muscles and metabolism themselves. Researchers have spent decades trying to sort out how much each factor contributes, and the honest answer is that it varies by person and by disease stage. But the broad picture is coming into focus.
Central Fatigue and Activation Failure
Part of what happens in ALS is that the brain loses its ability to fully “turn on” muscles during voluntary effort. When researchers compared voluntary force decline with the force decline produced by electrical stimulation (which bypasses the brain entirely), they found that the patterns were similar, but with a telling difference: at the end of a fatiguing exercise, ALS patients showed a meaningful increase in the additional force that could be squeezed out by superimposing electrical stimulation on top of voluntary effort. Healthy controls did not show the same gap. This pointed to a failure of central activation, where the brain’s descending signals to the muscle fall short of what the muscle could still produce.5Exploration of Neuroprotective Therapy. Muscle fatigue and exercise-related biomarkers in amyotrophic lateral sclerosis Upper motor neuron damage, the part of ALS that affects the brain and spinal cord pathways sending commands to muscles, reduces the voluntary drive available to power sustained activity.
Earlier work had come to a complementary conclusion. Researchers found that the compound electrical signals from muscle membranes held up during exercise in ALS patients, ruling out failure at the junction between nerve and muscle. But energy use inside the muscles was paradoxically lower than expected, again suggesting that muscles were not being fully activated by the nervous system in the first place.6PubMed. Physiology of fatigue in amyotrophic lateral sclerosis
Peripheral Factors and Overworked Motor Neurons
At the same time, the surviving motor neurons are not working under normal conditions. As some motor neurons die, the remaining ones sprout new branches to take over control of orphaned muscle fibers. This means each surviving nerve cell is firing at higher rates and controlling more muscle territory than it was designed for. Studies of nerve excitability during activity have shown that the electrical properties of motor axons in ALS change more dramatically with exercise than they do in healthy people, consistent with those nerves being pushed harder and recovering less efficiently.7Journal of Neurology, Neurosurgery & Psychiatry. Fatigue and activity dependent changes in axonal excitability in amyotrophic lateral sclerosis So even at the level of the surviving nerve fibers, the system is operating closer to its limit, making fatigue set in sooner.
Laboratory work using lab-grown nerve-muscle systems has added another piece. When researchers created co-cultures carrying ALS-related genetic mutations, the connections between nerve and muscle were less stable and the muscle fibers fatigued faster, even in the absence of the whole-body factors that complicate human studies.8PubMed. ALS mutations in both human skeletal muscle and motoneurons differentially affects neuromuscular junction integrity and function This suggests some component of fatigability is baked into the biology of ALS-affected cells themselves.
Energy Production Gone Wrong
Cells need a constant supply of energy in the form of ATP, and motor neurons are especially energy-hungry. Research in animal models of ALS has found that the ratio of ATP to its breakdown products is significantly lower in the motor cortex of ALS-affected animals, alongside a dramatic drop in a key metabolic molecule called NAD+. These shifts point to mitochondria, the cellular power generators, struggling to keep up with energy demand.9Scientific Reports. Mitochondrial dysregulation occurs early in ALS motor cortex with TDP-43 pathology and suggests maintaining NAD+ balance as a therapeutic strategy While this work has been done in mice rather than directly in human patients, it aligns with what clinicians observe: the disease appears to drain energy at a fundamental cellular level.
On top of cellular energy problems, about half of all ALS patients are hypermetabolic, meaning their bodies burn more energy at rest than predicted by their size and weight. One study found that hypermetabolic patients had resting energy expenditure roughly 20 percent above calculated values, and about 80 percent of them stayed that way over time.10PubMed. Hypermetabolism in ALS patients: an early and persistent phenomenon When your body is quietly burning more fuel than it should just to keep basic functions running, it is no surprise that you feel drained. This metabolic overdrive also helps explain why many ALS patients lose weight even before swallowing difficulties begin, with one study finding that over 38 percent of patients with weight loss had no significant dysphagia to account for it.11PubMed Central. Weight loss, dysphagia and supplement intake in patients with amyotrophic lateral sclerosis (ALS): impact on quality of life and therapeutic options
How Breathing Problems Feed Exhaustion
The diaphragm is just another muscle, and in ALS it is subject to the same progressive loss of motor neurons as the limbs. But because breathing is constant and automatic, diaphragmatic weakness has an outsized impact on fatigue. As diaphragm function deteriorates, the body recruits accessory muscles in the neck and chest to help with breathing. These muscles are less efficient than the diaphragm, and keeping them working around the clock is exhausting. The loss of motor units in the diaphragm leads to poor inspiratory strength, which in turn causes respiratory fatigue along with drops in oxygen and rises in carbon dioxide, often showing up first during sleep when you are lying flat.12PubMed Central. Diaphragmatic Neurophysiology and Respiratory Markers in ALS
This creates a vicious cycle with sleep. Disrupted nighttime breathing fragments sleep architecture, so you wake up unrefreshed, which compounds the fatigue from every other source. And breathing difficulties are not the only thing keeping people with ALS awake. Muscle cramps, pain, spasticity, difficulty turning over in bed, mucus buildup, and restless legs all interrupt sleep, while depression and anxiety can cause insomnia on top of everything else.13PubMed Central. Sleep disturbances in patients with amyotrophic lateral sclerosis: current perspectives Nocturnal hypoventilation, where breathing becomes too shallow during sleep to maintain adequate gas exchange, often precedes daytime respiratory failure and is one of the most important prognostic markers in ALS. The daytime exhaustion it produces can be mistaken for disease progression in general when it is actually a specific, treatable problem.
The Psychological Layer
Fatigue and depression travel together in ALS, but they are not the same thing. At baseline in one large study, 44 percent of patients had clinically significant fatigue, 7 percent had depression without fatigue, and 15 percent had both. Nearly half had neither condition.14PubMed. Prevalence of fatigue and depression in ALS patients and change over time This shows that while there is overlap, most fatigued ALS patients are not depressed, and treating depression alone would leave the fatigue of many patients unaddressed.
Anxiety, on the other hand, may play a larger role than depression in driving the subjective experience of exhaustion. A path analysis involving over 1,000 participants found that fatigue, anxiety, breathlessness, and disability together explained about 60 percent of the variation in quality of life.15PubMed. Fatigue and anxiety mediate the effect of dyspnea on quality of life in amyotrophic lateral sclerosis Fatigue and anxiety appear to mediate the way breathing difficulty translates into reduced quality of life: it is not just that you cannot breathe as well, but that the effort and worry involved in breathing amplify how drained you feel.
Researchers have also started teasing apart “physical” fatigue from “mental” fatigue in ALS. Physical fatigue correlates with anxiety and respiratory dysfunction, while mental fatigue, the kind that makes it hard to concentrate or sustain attention, correlates with memory impairment and apathy.16PubMed Central. Cognitive, behavioral, and brain functional connectivity correlates of fatigue in amyotrophic lateral sclerosis This distinction matters practically. If someone with ALS reports feeling mentally foggy and spent, the reflexive assumption might be that they are just physically tired. But cognitive changes are part of ALS in a significant minority of patients, and mental fatigue may reflect changes in brain networks rather than exhaustion from physical effort.
What Can Be Done About It
The uncomfortable truth is that high-quality evidence for fatigue treatment in ALS is thin. A Cochrane systematic review looking specifically at fatigue treatments in ALS and motor neuron disease found that the available studies were small and used the Fatigue Severity Scale as their primary measure, but the overall evidence base was not strong enough to support firm recommendations.17PubMed Central. Treatment of fatigue in amyotrophic lateral sclerosis/motor neuron disease That does not mean nothing helps. It means the field has not invested enough in rigorous trials for this particular symptom.
The most studied medication is modafinil, a wakefulness-promoting drug used for narcolepsy and shift-work sleep disorder. An initial open-label pilot with 15 ALS patients showed significant reductions in both fatigue and daytime sleepiness after two weeks of treatment.18PubMed. Modafinil to treat fatigue in amyotrophic lateral sclerosis: an open label pilot study A subsequent placebo-controlled study confirmed these results, finding response rates of 76 percent for modafinil compared to 14 percent for placebo, with no serious side effects.19PubMed. Modafinil treatment of fatigue in patients with ALS: a placebo-controlled study These are encouraging numbers, but the study was still small, and larger confirmatory trials have not been completed. In clinical practice, some neurologists prescribe modafinil off-label for ALS-related fatigue, particularly when daytime sleepiness is prominent.
Non-invasive ventilation, or NIV, is the clearest example of a treatment that addresses one of the root causes of fatigue. By supporting breathing with a mask-delivered device, NIV reduces the workload on accessory breathing muscles. One study found that NIV lowered resting energy expenditure by about 7 percent on average, reflecting the caloric savings from not having to power those extra muscles.20PubMed Central. Noninvasive ventilation reduces energy expenditure in amyotrophic lateral sclerosis Beyond the metabolic effect, NIV improves overnight oxygen levels and reduces carbon dioxide buildup, which translates into more restorative sleep and less daytime exhaustion. For many patients, starting NIV is the single intervention that produces the most noticeable improvement in how tired they feel.
Beyond these, managing fatigue in ALS is mostly about addressing its contributing streams one at a time. Treating pain and spasticity to improve sleep quality. Screening for and treating depression and anxiety. Ensuring adequate caloric intake, especially in patients who are hypermetabolic or losing weight without obvious swallowing problems. Pacing activities through the day to avoid the boom-and-bust pattern where a productive morning is followed by an afternoon of complete collapse. None of these individually eliminates the fatigue, but taken together they can meaningfully shift how much it intrudes on daily life.
Tracking Fatigue Over Time
One practical challenge is that fatigue is subjective, and the standard ALS functional rating scale does not capture it well. A patient can be declining in the ways the scale measures, like hand grip or walking speed, while their fatigue follows a different trajectory. Wearable sensors are starting to change this. Research using at-home wrist and ankle sensors combined with machine learning found that wearable-derived measures captured disease progression more sensitively than the standard clinical scale, with progression rates of about 0.86 standard deviations per year compared to 0.73 for traditional assessment.21PubMed Central. At-home wearables and machine learning sensitively capture disease progression in amyotrophic lateral sclerosis While this research focused on motor function broadly rather than fatigue specifically, the implication is that continuous real-world monitoring could eventually capture patterns of declining activity and increased rest that map onto the fatigue experience in ways a quarterly clinic visit cannot.
When Caregivers and Patients See Things Differently
Fatigue also creates a perception gap between people living with ALS and those caring for them. Research comparing patient self-reports with caregiver assessments found a consistent asymmetry: caregivers rated patients as having less energy, more suffering, and more weariness than the patients reported for themselves. At the same time, patients rated their caregivers as more burdened than caregivers acknowledged being.22PubMed. Disparities in perceptions of distress and burden in ALS patients and family caregivers Each side, in other words, projected more distress onto the other than the other person actually felt. This is not trivial. If a caregiver consistently overestimates how tired a patient is, they may push for more rest than the patient wants, limiting activity and independence. If a patient underreports fatigue to avoid worrying their caregiver, treatable factors like poor sleep or undertreated breathing difficulty go unaddressed. Open, honest conversations about energy levels, ideally guided by some form of tracking, can keep both sides calibrated with reality rather than assumption.